LLTP – Lightlake Therapeutics, promotional campaign starting Mar 16, 2011 @ 10:25 AM CST

on March 16, 2011 Stock Promotion Tracking and Tags: , , , with 0 comments

Summary

Start time:
10:25 AM
Start date:
March 16, 2011
Symbol:
LLTP
Company:
Lightlake Therapeutics
Stock promoter:
"Penny Stock Circle"
Campaign ID:
123

Lightlake Therapeutics

Employees:
-
Year of incorporation:
2005
Market capitalization:
$5,248,491
(as of July 23, 2013)
Business description:
Metal Mining
Website:
www.lightlaketherapeutics.com
Marketplace:
OTCQB
Floating shares:
-
Outsanding shares:
155,280,791
(as of June 14, 2013)
Authorized shares:
200,000,000
(as of August 5, 2009)

LLTP Promotional Newsletter

The following is a newsletter released by "Penny Stock Circle" promoting Lightlake Therapeutics

Caution

The following newsletter has not been verified for accuracy or completeness.
PSC

ALZM on Chart Breakout - LLTP Bounces off of Support

ALZM Continues Bullish Accumulation - LLTP Consolidates Recent Gains
March 17, 2011

Good Evening Traders,

We hope everyone had a productive trading day as well as a great St. Patricks day We have witnessed another solid session from ALZM Congratulations to readers who were able to take advantage of this report LLTP trend remains bullish after a bounce from support levels which created a potentially favorable accumulation opportunity. More info on ALZM and LLTP below...

We want to remind everyone that PSC alerts are generally short-term alerts. We alert on breaking stocks that make fast gains and provide amazing day-trade opportunities This often means get in fast and get out faster, and of course use established trading strategies and techniques. Beware of morning gaps and watch your investments closely. Those that trade responsibly also profit responsibly -

ALZM Allezoe Medical Holdings, Inc.

We initiated a technical alert on ALZM, when it was priced at $1.05 PPS. We observed ALZM as it reached a HOD of $1.48 PPS today, for a potential gain of 40% since our alert. Congratulations to readers who have bee

continued ...

PSC

ALZM on Chart Breakout - LLTP Bounces off of Support

ALZM Continues Bullish Accumulation - LLTP Consolidates Recent Gains
March 17, 2011

Good Evening Traders,

We hope everyone had a productive trading day as well as a great St. Patricks day We have witnessed another solid session from ALZM Congratulations to readers who were able to take advantage of this report LLTP trend remains bullish after a bounce from support levels which created a potentially favorable accumulation opportunity. More info on ALZM and LLTP below...

We want to remind everyone that PSC alerts are generally short-term alerts. We alert on breaking stocks that make fast gains and provide amazing day-trade opportunities This often means get in fast and get out faster, and of course use established trading strategies and techniques. Beware of morning gaps and watch your investments closely. Those that trade responsibly also profit responsibly -

ALZM Allezoe Medical Holdings, Inc.

We initiated a technical alert on ALZM, when it was priced at $1.05 PPS. We observed ALZM as it reached a HOD of $1.48 PPS today, for a potential gain of 40% since our alert. Congratulations to readers who have been able to participate in this profitable report

ALZM has been making new highs on a daily basis and today was no exception. Today's session had two predominate runs which were both able to achieve new highs.

Substantial interest continues to build momentum which has driven the steady gains. ALZM was one of the top traded stocks on the OTC market once again today.

Allezoe Medical Holdings, Inc. acquired Organ Transport Systems, Inc. in a reverse merger transaction. Organ Transport Systems, Inc. is a dynamic medical technology company based in Frisco, Texas.

Momentum plays can become volatile as time progresses so remember to monitor your investments closely and capitalize when the time is right

Remember to trade smart, research your options, and use due diligence

To view ALZM's current chart and quote, please visit

About Allezoe Medical Holdings, Inc.

Allezoe Medical Holdings, Inc. acquired Organ Transport Systems, Inc. in a reverse merger transaction. Organ Transport Systems, Inc. is a dynamic medical technology company based in Frisco, Texas. The Company has developed human organ preservation technologies designed to revolutionize the organ transplantation industry by dramatically improving the quality and increasing the availability of vital organs. The Companys strategic goal is to be the worldwide leader of technologically advanced products and services for the entire organ preservation and enhancement market. The organ transplant market is approximately $9 billion in the U.S., of which $1.8 billion is spent on organ procurement and transportation.

LLTP Lightlake Therapeutics, Inc.

We initiated a fundamental research report on LLTP yesterday, when it was priced at $0.69 PPS. LLTP opened at the HOD of $0.75 before a pullback to support on light volume. The stock spent the majority of the session in consolidation before closing near the high of day at $0.74 PPS.

The company will be in an excellent position with their FDA approval. Their patented treatments for obesity due to BED Binge Eating Disorder could attain a large portion of the potential $200 Billion market. It appears that shareholders are holding onto LLTP as the company closes in on the release of their revolutionary treatments.

As LLTP continues to make positive progress, we expect that the PPS could react similarly.

Lightlake Therapeutics Inc. focuses on operating as a pharmaceutical company that develops solutions to obesity and eating disorders. Phase II clinical trials are funded and patient testing has commenced in an EU approved facility to evaluate the efficacy of an opioid antagonist nasal spray for patients who are obese due to BED Binge Eating Disorder.

Keep research report LLTP on the top of your watchlist for a potential breakout.

Remember to trade smart, research your options, and use due diligence

To view LLTP's current chart and quote, please visit

About Lightlake Therapeutics, Inc.

Lightlake Therapeutics is a biopharmaceutical company building a solid platform of pharmacological treatments based on their extensive expertise using opioid antagonists. They have developed and patented innovative biopharmaceutical solutions to treat common addictive disorders. Lightlake was founded in 2009 to develop a safe and effective treatment for obesity.

You may contact Penny Stock Circle at mailpennystockcircle.com or by replying directly to this newsletter.

Disclaimer and Release of Liability
PennyStockCircle is owned and operated by Global Marketing Media LLC. Any compensation received by Global Marketing Media LLC constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. A third party of Global Marketing Media LLC may have shares and may liquidate, which may negatively affect the stock price. Global Marketing Media LLC affiliates may at any time have a position in the securities mentioned herein and may increase or decrease such positions without notice which will negatively affect the market.

We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. PennyStockCircles sponsored advertisements do not purport to provide an analysis of any companys financial position, operations or prospects and this is not to be construed as a recommendation by PennyStockCircle or an offer or solicitation to buy or sell any security. Neither the owner of PennyStockCircle nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases. It is possible that a viewers entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed in a release or on our website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. To review our complete disclaimer and additional information, please visit www. PennyStockCircle .com. PennyStockCircle makes no recommendation that the securities of the companies profiled or discussed in our releases or on our website should be purchased, sold or held by investors.

Some of the content in this release contains forward - looking information within the meaning of Section 27 A of the Securities Act of 1 9 9 3 and Section 21 E of the Securities Exchange Act of 1 9 3 4 including statements regarding expected continual growth of the profiled company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect a company's actual results of operation. A company's actual performance could greatly differ from those described in any forward - looking statements or announcements mentioned in this release. Factors that should be considered that could cause actual results to differ include the size and growth of the market for the company's products the company's ability to fund its capital requirements in the near term and in the long term pricing pressures unforeseen andor unexpected circumstances in happenings etc. and the risk factors and other factors set forth in the companys filings with the Securities and Exchange Commission. However, a companys past performance does not guarantee future results.

Generally, the information regarding a company profiled is provided from public sources which we believe to be reliable but is not guaranteed by us as being accurate. Further specific financial information, filings and disclosures as well as general investor information about the profiled company, advice to investors and other investor resources are available at the Securities and Exchange Commission SEC website www.sec.gov and the Financial Industry Regulatory Authority FINRA website at www.finra.org. Any investment should be made only after consulting with a qualified investment advisor and reviewing the publicly available financial statement and other information about the company profiled and verifying that the investment is appropriate and suitable. PennyStockCircle makes no representations, warranties or guarantees as to the accuracy or completeness of the information provided or discussed. Viewers should not rely solely on the information obtained in this release or on our website. Viewers should use the information provided by us regarding the profiled companies as a starting point for additional independent research on the companies profiled or discussed in order to allow the viewer to form his or her own opinion regarding investing in the securities of such companies. Factual statements, or the similar, made by the profiled companies are made as of the date stated and are subject to change without notice and PennyStockCircle has no obligation to update any of the information provided. PennyStockCircle, its owners, officers, directors, contractors and employees are not responsible for errors and omissions.

From time to time certain content in our releases or website is written and published by our employees or third parties. In addition to information about our profiled companies, from time to time, our releases and website will contain the symbols of companies andor news feeds about companies that are not being profiled by us but are merely illustrative of certain activity in the micro cap or penny stock market that we are highlighting. Viewers are advised that all analysis reports and news feeds are issued solely for informational purposes. Any opinions expressed are subject to change without notice. It is also possible that one or more of the companies discussed or profiled in our release or on our website may not have approved certain or any statements within the website. PennyStockCircle encourages viewers to supplement the information obtained from this release and our website with independent research and other professional advice. The content in this release is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data.

This release may provide hyperlinks to third party websites or access to third party content. PennyStockCircle, its owners, officers, directors, contractors and employees are not responsible for errors and omissions nor does PennyStockCircle control, endorse, or guarantee any content found in such sites. By accessing, viewing, or using the website or communications originating from this release, you agree that PennyStockCircle, its owners, officers, directors, contractors and employees, are not responsible for any content, associated links, resources, or services associated with a third party website. You further agree that PennyStockCircle, its owners, officers, directors, contractors and employees shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only.

PennyStockCircle uses third parties to disseminate information to subscribers. Although we take precautions to prevent others from obtaining our subscriber list, there is a risk that our subscriber list, through no wrong doing on our part, could end up in the hands of an unauthorized party and that subscribers will receive communications from unauthorized third parties.

You agree to hold PennyStockCircle, its operators, owners and employees harmless and to completely release them from any and all liability due to any and all loss monetary or otherwise, damage monetary or otherwise, or injury monetary or otherwise that you may incur arising out of the use of our website or the information in our press releases, profiles and opinions. You agree that use of our website is at your sole risk. PennyStockCircle disclaims all warranties of any kind, express or implied.

We encourage viewers to invest carefully and read the investor issuer information available at the web sites of the SEC. The SEC has launched an investor-focused website to help you invest wisely and avoid fraud at www.investor.gov and filings made by public companies can be viewed at www.sec.gov andor then FINRA at www.finra.org. In addition, FINRA has published information at its website on how to invest carefully at www.finra.orgInvestorsindex.htm.

This message was sent to from

Global Marketing Media 136 Wappoo Creek Dr. Charleston, SC 29412

Email Marketing by

What does the LLTP stock promotion mean for you?

Read more about penny stock promotions to understand what penny stock promotions mean to you as an investor in Lightlake Therapeutics

Note

OTC Dynamics is not affiliated with the company being promoted or the associated stock promoter.

The information on this page is not a recommendation to buy or sell securities.